# Levetiracetam in Central Pain in Multiple Sclerosis(MS)

> **NCT00423527** · PHASE4 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** levetiracetam

## Key facts

- **NCT ID:** NCT00423527
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423527, "Levetiracetam in Central Pain in Multiple Sclerosis(MS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00423527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
